Isofol Says Agent Study Confirms Topline Results

 Isofol Says Agent Study Confirms Topline Results
Image source: ©2022 Kalkine Media®

Nov 25 (Reuters) - Isofol Medical AB (publ):


* FINAL DATA FROM THE AGENT STUDY CONFIRMS TOPLINE RESULTS

* ANALYSIS OF AGENT STUDY'S FINAL DATA CONFIRMED TOPLINE RESULTS PRESENTED ON AUGUST 3, 2022

* ISOFOL IS IN PARALLEL CONTINUING TO INVESTIGATE POSSIBLE FUTURE PATHS FORWARD FOR COMPANY Source text for Eikon: Further company coverage: (Gdansk Newsroom)

Disclaimer

The above content is directly sourced from Reuters under a contractual arrangement. The content is being provided as a convenience and for informational purposes only; and does not constitute an endorsement or approval by Kalkine Media of any of the products, services, or opinions of the organization or individual. The user is apprised that Kalkine Media bears no responsibility for the accuracy, legality, or content of Reuters, any external sites, or for that of subsequent links. The user is requested to contact Reuters directly for answers to questions regarding the content. Please note that Kalkine Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.